Ledger.Open graph →
SEC Form D · filed July 14, 2015

Urigen Pharmaceuticals, Inc

Offering
$12.4M
Sold
$300K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NORTH BRUNSWICK, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

C. L. Parsons · North Brunswick, NJDirectorMichael J. Nordlicht · North Brunswick, NJDirectorMichael J. Goldberg · North Brunswick, NJDirectorMark J. Rosenblum · North Brunswick, NJExecA. L. Maasdorp · North Brunswick, NJDirectorMichael J. Goldberg · North Brunswick, NJDirectorC. L. Parsons · North Brunswick, NJDirectorMichael J. Nordlicht · North Brunswick, NJDirectorMark J. Rosenblum · North Brunswick, NJExecA. L. Maasdorp · North Brunswick, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗